Millie Erickson, MD
Urology · North Platte, NENPI 1033374525
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $2,245 of the $3,680 with a category attached, or 61.0%. 9 manufacturers reported payments, led by Teleflex LLC at 51.9% of the total. Reporting peaked in 2022 at $1,769 and has fallen 91.4% since, to $152 in 2025.
Across 45 payments — averaging $81.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teleflex LLC$2K
- Procept Biorobotics Corporation$2K
- Rochester Medical Corporation$68
- KARL Storz Endoscopy-america$65
- Laborie Medical Technologies Corp.$27
- Boston Scientific$21
- plus $46 from 3 others
What the payments were for
- Travel & lodging$2,24561%
- Food & beverage$1,43539%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teleflex LLC | 21 | $1,909 |
| Procept Biorobotics Corporation | 10 | $1,544 |
| Rochester Medical Corporation | 5 | $68 |
| KARL Storz Endoscopy-america | 2 | $65 |
| Laborie Medical Technologies Corp. | 2 | $27 |
| Boston Scientific | 1 | $21 |
| AbbVie | 1 | $19 |
| Astellas Pharma US Inc | 2 | $15 |
| SRS Medical Systems, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AquaBeam Robotic System$1,395
- UroLift$1,293
- UroLift System$189
How this compares
$3,680 in reported general payments places this provider in the 55th percentile of 79 urology providers in Nebraska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 119 | $65,211 |
| Tamsulosin Hcl | 482 | $14,394 |
| Methenamine Hippurate | 127 | $7,816 |
| Oxybutynin Chloride ErOxybutynin Chloride | 231 | $5,058 |
| Dutasteride | 100 | $2,971 |
| Potassium Citrate ErPotassium Citrate | 26 | $2,541 |
| Trimethoprim | 23 | $1,580 |
| Cephalexin | 80 | $908 |
| Finasteride | 42 | $768 |
| NitrofurantoinNitrofurantoin Macrocrystal | 24 | $748 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 19 | $388 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 72 | $322 |
| Solifenacin Succinate | 13 | $293 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 68 | $206 |
| Ciprofloxacin Hcl | 62 | $185 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $15 | $65,211119 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 79 urology providers in Nebraska.
Other urology in North Platte
- John BishayOmaha$138K
- Garrett PohlmanKearney$123K
- Rebecca McCreryOmaha$71K
- Judson DaviesOmaha$67K
- Stefanie BolteOmaha$59K
- Antonio BeltranLincoln$51K
- Michael FeloneyOmaha$29K
- Ansar KhanFremont$15K
- Don HensleeFairbury$15K
- Thomas BrushLincoln$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.